Retrophin to Highlight Fosmetpantotenate Program for PKAN at Upcoming Medical Congresses
RETROPHIN INC (RTRX)
Last retrophin inc earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.retrophin.com/investor-relations
Company Research
Source: GlobeNewswire
SAN DIEGO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that presentations highlighting the design of the ongoing pivotal Phase 3 FORT Study of fosmetpantotenate for the treatment of pantothenate kinase-associated neurodegeneration (PKAN), the patient and caregiver experience with PKAN, and the diagnostic pathway and clinical experience of patients with PKAN, will be presented by the Company and its collaborators at upcoming medical congresses in October. Abstract Title: The Fosmetpantotenate Replacement Therapy (FORT) Pivotal Trial: Utilization of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration Meeting: International Congress of Parkinson’s Disease and Movement Disorders® (MDS), taking place from October 5-9, 2018, in Hong Kong.Abstract Program #: 25Poster Session: Clinical Trials and Therapy in Movement DisordersLocation: Hall 3FG, Hong Kong Convention and Exhibition CentreDate & Time: Satu
Show less
Read more
Impact Snapshot
Event Time:
RTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RTRX alerts
High impacting RETROPHIN INC news events
Weekly update
A roundup of the hottest topics